10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
Tuesday, March 26, 2024 1 min read
Key Takeaway: 10x Genomics has announced the commercial launch of its Visium HD Spatial Gene Expression assay. This new product allows researchers to conduct whole transcriptome analysis at single cell-scale resolution, specifically from FFPE tissue sections. The global shipments for Visium HD have already begun, marking a significant advancement in spatial biology.
Price reaction · baseline $36.32 (2024-03-26T13:59:00.000Z) · hit during market hours · clean, no other TXG news in the window
day 0 close · peak
-0.2%
Market Sentiment Analysis
POSITIVE FACTORS
Launch of Visium HD enhances spatial gene expression research.
Enables whole transcriptome analysis at single cell resolution.
Supports researchers working with FFPE tissue sections.
Full Press Release Details
Began global shipments for Visium HD, a new product that enables whole transcriptome spatial discovery at single cell–scale resolution
PLEASANTON, Calif.,March 26, 2024/PRNewswire/ --10x Genomics, Inc.(Nasdaq:TXG), a leader in single cell and spatial biology, announced today the commercial availability of itsVisium HDSpatial Gene Expressionproduct. This assay enables researchers to measure the whole transcriptome from FFPE tissue sections at single cell-scale resolution.
Frequently Asked Questions
What is the Visium HD assay?
The Visium HD assay is a product by 10x Genomics that enables whole transcriptome spatial discovery at single cell-scale resolution.
What type of tissue can be analyzed with Visium HD?
The Visium HD assay can analyze FFPE (formalin-fixed, paraffin-embedded) tissue sections.
When did 10x Genomics start shipping Visium HD?
10x Genomics began global shipments of the Visium HD assay on March 26, 2024.
What is the significance of single cell resolution?
Single cell resolution allows for more precise measurement of gene expression at the individual cell level.